Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Insulin glulisine
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Apidra 100units/ml inj 3ml pre-filled SoloStar pens
0601011P0BBAEAC
|
Insulin Apidra | Insulin glulisine | Endocrine System | 20,606 |
|
Apidra 100units/ml solution for injection 3ml cartridges
0601011P0BBABAB
|
Insulin Apidra | Insulin glulisine | Endocrine System | 2,397 |
|
Apidra 100units/ml solution for injection 10ml vials
0601011P0BBAAAA
|
Insulin Apidra | Insulin glulisine | Endocrine System | 1,460 |
|
Insulin glulisine 100units/ml inj 3ml pf dispos dev
0601011P0AAACAC
|
Insulin glulisine | Insulin glulisine | Endocrine System | 327 |
|
Insulin glulisine 100units/ml inj 10ml vials
0601011P0AAAAAA
|
Insulin glulisine | Insulin glulisine | Endocrine System | 56 |
|
Insulin glulisine 100units/ml inj 3ml cartridges
0601011P0AAABAB
|
Insulin glulisine | Insulin glulisine | Endocrine System | 44 |
|
Apidra 100units/ml inj 3ml OptiClik cartridges
0601011P0BBADAB
|
Insulin Apidra | Insulin glulisine | Endocrine System | No data available |
|
Apidra 100units/ml inj 3ml pre-filled OptiSet pens
0601011P0BBACAC
|
Insulin Apidra | Insulin glulisine | Endocrine System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.